Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_assertion type Assertion NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_head.
- NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_assertion wasGeneratedBy ECO_0000203 NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_provenance.
- NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_assertion wasDerivedFrom befree-20140225 NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_provenance.
- NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_assertion SIO_000772 9103677 NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_provenance.
- NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_assertion evidence source_evidence_literature NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_provenance.
- NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_assertion description "[The vast majority of cases of APL are associated with t(15; 17) leading to the formation of PML-RAR alpha, RAR alpha-PML and aberrant PML fusion products.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207979.RAS_KUhrmyLBhCCEjPT4tuFxEYAA9TXB7vmPxr6jyjNfE130_provenance.